Publication | Closed Access
Impact of treatment with saxagliptin on glycaemic stability and β‐cell function in the <scp>SAVOR‐TIMI</scp> 53 study
33
Citations
23
References
2015
Year
Saxagliptin improved glycaemia and prevented the reduction in HOMA-2β values. Saxagliptin may reduce the usual decline in β-cell function in T2D, thereby slowing diabetes progression.
| Year | Citations | |
|---|---|---|
Page 1
Page 1